美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
60219-2033-1	60219-2033	HUMAN PRESCRIPTION DRUG	Carbidopa and Levodopa	CARBIDOPA and LEVODOPA	TABLET, EXTENDED RELEASE	ORAL	20221221	N/A	ANDA	ANDA076521	Amneal Pharmaceuticals NY LLC	CARBIDOPA; LEVODOPA	25 mg/1; 100 mg/1	100 TABLET, EXTENDED RELEASE in 1 BOTTLE (60219-2033-1)
60219-2033-3	60219-2033	HUMAN PRESCRIPTION DRUG	Carbidopa and Levodopa	CARBIDOPA and LEVODOPA	TABLET, EXTENDED RELEASE	ORAL	20221221	N/A	ANDA	ANDA076521	Amneal Pharmaceuticals NY LLC	CARBIDOPA; LEVODOPA	25 mg/1; 100 mg/1	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (60219-2033-3)
60219-2033-5	60219-2033	HUMAN PRESCRIPTION DRUG	Carbidopa and Levodopa	CARBIDOPA and LEVODOPA	TABLET, EXTENDED RELEASE	ORAL	20221221	N/A	ANDA	ANDA076521	Amneal Pharmaceuticals NY LLC	CARBIDOPA; LEVODOPA	25 mg/1; 100 mg/1	500 TABLET, EXTENDED RELEASE in 1 BOTTLE (60219-2033-5)
60219-2034-1	60219-2034	HUMAN PRESCRIPTION DRUG	Carbidopa and Levodopa	CARBIDOPA and LEVODOPA	TABLET, EXTENDED RELEASE	ORAL	20221221	N/A	ANDA	ANDA076521	Amneal Pharmaceuticals NY LLC	CARBIDOPA; LEVODOPA	50 mg/1; 200 mg/1	100 TABLET, EXTENDED RELEASE in 1 BOTTLE (60219-2034-1)
60219-2034-3	60219-2034	HUMAN PRESCRIPTION DRUG	Carbidopa and Levodopa	CARBIDOPA and LEVODOPA	TABLET, EXTENDED RELEASE	ORAL	20221221	N/A	ANDA	ANDA076521	Amneal Pharmaceuticals NY LLC	CARBIDOPA; LEVODOPA	50 mg/1; 200 mg/1	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (60219-2034-3)
60219-2034-5	60219-2034	HUMAN PRESCRIPTION DRUG	Carbidopa and Levodopa	CARBIDOPA and LEVODOPA	TABLET, EXTENDED RELEASE	ORAL	20221221	N/A	ANDA	ANDA076521	Amneal Pharmaceuticals NY LLC	CARBIDOPA; LEVODOPA	50 mg/1; 200 mg/1	500 TABLET, EXTENDED RELEASE in 1 BOTTLE (60219-2034-5)